Expression of protective genes in human renal allografts: a regulatory response to injury associated with graft rejection1,2
Authors:
- Naili MaNMNaili Ma
- Eva CsizmadiaECEva Csizmadia
- Candace WangCWCandace Wang
- Martha PavlakisMPMartha Pavlakis
- Mauricio GiraldoMGMauricio Giraldo
- Terry B. StromTSTerry B. Strom
- Miguel P. SoaresMSMiguel P. Soares
- Christiane FerranCFChristiane Ferran
- 1 April 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 73 (7) , 1079-1085
Abstract
Long-term survival of a graft requires inhibition of host immune effectors, but protective responses emanating from the graft might be equally important. Expression of the “protective” genes A20, heme-oxygenase-1 (HO-1), and Bcl-xL in rodent allo and xenografts correlates with long-term survival. Little is known of the pattern of expression of such protective genes and the implication thereof in clinical transplantation. We analyzed, by quantitative reverse-transcriptase polymerase chain reaction (RT-PCR) and immunohistochemistry, expression of A20, HO-1, and Bcl-xL in 31 renal allograft biopsies from patients with suspected rejection. A20 is not expressed in nonrejecting (NR) grafts. Its expression is increased in grafts undergoing acute and chronic rejection (AR and CR) but is weaker in CR. HO-1 is not expressed in NR grafts; it is up-regulated in AR but not CR. Bcl-xL is detected in all biopsies with decreased levels in CR. Expression of A20, HO-1, and Bcl-xL localizes mainly to endothelial, smooth muscle, and infiltrating mononuclear cells. This data demonstrate that A20 and HO-1 are up-regulated in response to immune injury inferred by AR. Given the antiapoptotic and antiinflammatory functions of these genes, we hypothesize that their expression survives to limit graft injury by maintaining cell viability and controlling inflammation. Their reduced expression in CR as compared with AR represents either inadequate response to injury or a sequelae of prior injury that jeopardizes further tissue response to immune attack.Keywords
This publication has 37 references indexed in Scilit:
- Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genesNature Medicine, 1998
- Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection.Journal of Clinical Investigation, 1998
- Protective genes expressed in endothelial cells: a regulatory response to injuryImmunology Today, 1997
- Accommodation of vascularized xenografts: Expression of “protective genes” by donor endothelial cells in a host Th2 cytokine environmentNature Medicine, 1997
- Life, death, and the pursuit of apoptosis.Genes & Development, 1996
- Renal TransplantationNew England Journal of Medicine, 1994
- IMPLICATIONS OF DE NOVO ELAM-1 AND VCAM-1 EXPRESSION IN HUMAN CARDIAC ALLOGRAFT REJECTIONTransplantation, 1993
- THE ROLE OF ENDOTHELIAL CELLS IN INFLAMMATIONTransplantation, 1990
- Leukocyte adhesion to endothelium in inflammationCell, 1990
- The potential roles of vascular endothelium in immune reactionsHuman Immunology, 1990